Dyslipidemia and Hypertension Among Type 2 Diabetics at a Tertiary Care Hospital of South Gujarat, India

Jash Kotak; Kirtida Tandel; Mithil Kotak; Diwakar Sharma

doi:10.51957/Healthline_687_2025

Authors

Jash Kotak Medical Officer, GMERS Medical College and Hospital, Valsad, India Author https://orcid.org/0009-0008-2403-8149
Kirtida Tandel Professor and Head, Department of Pharmacology, GMERS Medical College and Hospital, Valsad, India Author
Mithil Kotak Indian Institute of Science Education and Research (IISER), Pune, India Author https://orcid.org/0009-0009-8928-0216
Diwakar Sharma Statistician, Department of Preventive and Social Medicine, GMERS Medical College and Hospital, Valsad, India Author https://orcid.org/0000-0003-4278-5187

DOI:

https://doi.org/10.51957/Healthline_687_2025

Keywords:

Blood sugar, Diabetes, Dyslipidemia, Hypertension, lipid profile

Abstract

Introduction: The number of diabetes cases are rising globally along with comorbidities like hypertension and dyslipidemia. Objectives: To estimate the prevalence of dyslipidemia and hypertension in type 2 diabetes (T2DM) patients of Valsad, Gujarat, India. Methods: This is a cross-sectional study of total 62 blood samples of T2DM patients selected by convenience sampling which analysed fasting blood sugar (FBS), postprandial blood sugar (PP2BS), cholesterol, triglyceride (TG) and high-density lipoprotein (HDL) using standard methods at a tertiary care hospital of Valsad. Low density lipoprotein (LDL) and very low-density lipoprotein (VLDL) were also estimated using Martin-Hopkins and Friedewald equations respectively. Results: In study participants, 11.29% had neither hypertension (HTN) nor dyslipidemia, 64.52% had HTN, 77.42% had dyslipidemia and 53.22% patients had HTN and dyslipidemia along with diabetes. Conclusion: Results suggest a high prevalence of dyslipidemia and HTN in study subjects. Early screening and administration of lipid-lowering agents are required in these patients.

References

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90. doi: 10.2337/dc14-S081. PMID: 24357215.

2. Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS [Internet]. 10th ed. Brussels: International Diabetes Federation; 2021. PMID: 35914061.

3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442. doi: 10.1371/journal.pmed.0030442. PMID: 17132052; PMCID: PMC1664601.

4. Chattanda S, Mgonda Y. Diabetic Dyslipidemia Among Diabetic Patients Attending Specialized Clinics in Dar es Salaam. Tanzan Med J. 2008 ;23(1):8–11. doi: 10.4314/tmj.v23i1.39221

5. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010 Mar 4;362(9):800-11. doi: 10.1056/NEJMoa0908359. PMID: 20200384; PMCID: PMC2872990.

6. Eriksson M, Zethelius B, Eeg-Olofsson K, Nilsson PM, Gudbjörnsdottir S, Cederholm J, Eliasson B. Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register. Eur J Cardiovasc Prev Rehabil. 2011 Feb;18(1):97-105. doi: 10.1097/HJR.0b013e32833ba61e. PMID: 21354969.

7. Wang Y. Higher fasting triglyceride predicts higher risks of diabetes mortality in US adults. Lipids Health Dis. 2021 Dec 20;20(1):181. doi: 10.1186/s12944-021-01614-6. PMID: 34930280; PMCID: PMC8686260.

8. Pietri AO, Dunn FL, Grundy SM, Raskin P. The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus. Diabetes. 1983 Jan;32(1):75-81. doi: 10.2337/diab.32.1.75. PMID: 6848399.

9. Teuscher A, Egger M, Herman JB. Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population. Arch Intern Med. 1989 Sep;149(9):1942-5. doi: 10.1001/archinte.149.9.1942. PMID: 2774774.

10. Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021 Nov;78(5):1197-1205. doi: 10.1161/HYPERTENSIONAHA.121.17981. Epub 2021 Oct 4. PMID: 34601960; PMCID: PMC8516748.

11. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992 Jan;152(1):56-64. PMID: 1728930.

12. Song Y, Liu X, Zhu X, Zhao B, Hu B, Sheng X, Chen L, Yu M, Yang T, Zhao J. Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999-2012. Sci Rep. 2016 Nov 2;6:36093. doi: 10.1038/srep36093. PMID: 27805013; PMCID: PMC5090961.

13. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord. 2001 Nov;25(11):1722-9. doi: 10.1038/sj.ijo.0801748. Erratum in: Int J Obes Relat Metab Disord. 2002 Sep;26(9):1281. PMID: 11753596.

14. Pandya H, Lakhani JD, Dadhania J, Trivedi A. The Prevalence and Pattern of Dyslipidemia among Type 2 Diabetic Patients at Rural Based Hospital in Gujarat, India. Indian Journal of Clinical Practice 2012;22(12):36-44.

15. Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013 Nov 20;310(19):2061-8. doi: 10.1001/jama.2013.280532. PMID: 24240933; PMCID: PMC4226221.

16. LDL Calculator [Internet]. Johns Hopkins University; c2022 [cited 2022 Oct 30]. Available from: https://ldlcalculator.com/

17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499-502. doi: 10.1093/clinchem/18.6.499. PMID: 4337382.

18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486. PMID: 11368702.

19. World Health Organization. Regional Office for the Western Pacific. (‎2000)‎. The Asia-Pacific perspective : redefining obesity and its treatment. Sydney : Health Communications Australia.

20. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc. 1998 Oct;73(10):969-76. doi: 10.4065/73.10.969. PMID: 9787748.

21. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001 Sep 20;345(12):861-9. doi: 10.1056/NEJMoa011161. PMID: 11565518.

22. Borle AL, Chhari N, Gupta G, Bathma V. Study of prevalence and pattern of dyslipidaemia in type 2 diabetes mellitus patients attending rural health training centre of medical college in Bhopal, Madhya Pradesh, India. Int J Community Med Public Health. 2017 Jan. 31;3(1):140-4. doi: 10.18203/2394-6040.ijcmph20151549

23. Dixit AK, Dey R, Suresh A, Chaudhuri S, Panda AK, Mitra A, Hazra J. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital. J Diabetes Metab Disord. 2014 May 22;13:58. doi: 10.1186/2251-6581-13-58. PMID: 24918095; PMCID: PMC4051117.

24. Parikh RM, Joshi SR, Menon PS, Shah NS. Prevalence and pattern of diabetic dyslipidemia in Indian type 2 diabetic patients. Diabetes Metab Syndr Clin Res Rev. 2010;4(1):10–12. doi: 10.1016/j.dsx.2009.04.005

25. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care. 1998 Aug;21(8):1258-65. doi: 10.2337/diacare.21.8.1258. PMID: 9702430.

26. Pokharel DR, Khadka D, Sigdel M, Yadav NK, Acharya S, Kafle R, Sapkota RM, Sigdel T. Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes. BMC Res Notes. 2017 Apr 4;10(1):146. doi: 10.1186/s13104-017-2465-4. PMID: 28376848; PMCID: PMC5379598.

27. Lin H, Li Q, Hu Y, Zhu C, Ma H, Gao J, Wu J, Shen H, Jiang W, Zhao N, Yin Y, Pan B, Jeekel J, Hofman A, Gao X. The prevalence of multiple non-communicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study. Eur J Epidemiol. 2017 Feb;32(2):159-163. doi: 10.1007/s10654-016-0219-6. Epub 2016 Dec 20. PMID: 27999971.

28. Tripathy JP, Thakur JS, Jeet G, Jain S. Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S459-S465. doi: 10.1016/j.dsx.2017.03.036. Epub 2017 Mar 31. PMID: 28395951.

29. Berraho M, El Achhab Y, Benslimane A, El Rhazi K, Chikri M, Nejjari C. Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study). Pan Afr Med J 2012;11:52.

30. Otieno CF, Vaghela V, Mwendwa FW, Kayima JK, Ogola EN. Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi. East Afr Med J. 2005 Dec;82(12 Suppl):S184-90. doi: 10.4314/eamj.v82i12.9380. PMID: 16619731.

31. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes. 2013 Sep 17;6:327-38. doi: 10.2147/DMSO.S51325. PMID: 24082791; PMCID: PMC3785394.

32. Chen G, McAlister FA, Walker RL, Hemmelgarn BR, Campbell NR. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011 May;57(5):891-7. doi: 10.1161/hypertensionaha.110.162446. Epub 2011 Mar 14. PMID: 21403089; PMCID: PMC3785072.